Influence of angiotensin II receptors blocking on overall left ventricle's performance of patients with acute myocardial infarction of limited extent. Echocardiographic assessment

International Journal of Cardiovascular Imaging

Volumn 22, Issue 2, 2006, Pages 191-198

  Nearchou, Nearchos S ^a,b   Tsakiris, Alexandros K ^a   Lolaka, Maria D ^a   Karatzis, Emmanouil N ^a   Tsiafoutis, Ioannis N ^a   Flessa, Constantina D ^a   Bogiatzis, Dimitrios T ^a   Zarcos, Ilias ^a   Skoufas, Panagiotis D ^a  

^a RED CROSS HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Acute myocardial infarction of limited extent; Irbesartan; Tei index

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HEPARIN; IRBESARTAN; NITRATE; PLACEBO;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFICACY; FEMALE; HEART CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE RELAXATION; HEMODYNAMICS; HUMAN; MALE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 33645760444     PISSN: 15695794     EISSN: 18758312     Source Type: Journal    
DOI: 10.1007/s10554-005-9027-x     Document Type: Article

References (29)

1. Pfeffer M, Braunwald E, Moye L, et al. (1992). Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 327:369-77
2. Pfeffer M, Lamas G, Vaughan D, Parisi A, Braunwald E. (1988). Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 319:80-6
3. Sharpe N, Smith H, Murphy J, Greaves S, Hart H, Gamble G. (1991). Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin converting-enzyme inhibition. Lancet 337:872-6
4. The Acute Infarction Ramipril Efficacy (AIRE) (1993). Study Investigators: Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342:821-8
5. Grouppo Italiano per Io Studio della Streptochinasi nell' Infarcto Miocardico. (1994). GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after myocardial infarction. Lancet 343:1115-21
6. Goodfriend T, Elliott M, Catt K. (1996). Angiotensin receptors and their antagonists. N Engl J Med 334:1649-54
7. Petrie M, Padmanabhan N, McDonald J, Hillier C, Connell J, McMurray J. (2001). Angiotensin converting enzyme (ACE) and non ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease. J Am Coll Cardiol 37:1056-61
8. Stumpe K, Haworth D, Hoglund C, et al. (1998). Comparison of the angiotensin II receptor antagonist irbesartan with atenolol for treatment of hypertension. Blood Press 7:31-7
9. St John's University College of Pharmacy, 8000 Utopia Parkaway, NY 11439. (2001). USA: Angiotensin II receptor blockers for the treatment of hypertension. Expert Opin Pharmacother 2:1795-804
10. Pitt B, Segal R, Martinez F, et al. (1997). Randomized trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 349:747-52
11. Pitt B, Poole-Wilson P, Segal R, et al. (1999). Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: Rationale, design and baseline characteristics of patients in the Losartan Heart Failure Survival Study- ELITE II. J Card Fail 5:146-54
12. Parving H, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P. (2001). Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group. The effects of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345:870-8
13. Lewis E, Hunsicker L, Clarke W, et al. (2001). Collaborative Study Group. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851-60
14. Dickstein K, Kjekshus J. (2002). Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: The OPTIMAAL randomized trial. Lancet 360:752-60
15. Preffer M, McMurray J, Velazquez E, et al. (2003). Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both (VALsartan In Acute myocardial iNfarcTion, VALIANT). N Engl J Med 349:1893-906
16. Rakowski H, Appleton C, Chan K, et al. (1996). Canadian Consensus Recommendations for the Measurement and Reporting of Diastolic Dysfunction by Echocardiography. J Am Soc Echocardiogr 9:736-60
17. Rokey R, Kuo L, Zoghbi W, et al. (1985). Determination of parameters of left ventricular diastolic filling with pulsed Doppler echocardiography: comparison with cineangiography. Circulation 71:543-50
18. Spirito P, Maron B, Bonow R. (1986). Noninvasive assessment of left ventricular diastolic function: Comparative analysis of Doppler echocardiography and radionuclide angiographic techniques. J Am Coll Cardiol 7:518-25
19. Dujardin K, Tei C, Yeo T, Hodge D, Rossi A, Seward J. (1998). Prognostic value of a doppler index combining systolic and diastolic performance in idiopathic-dilated cardiomyopathy. Am J Cardiol 82:1071-76
20. Bruch C, Schmermund A, Marin D, et al. (2000). Tei index in patients with mild to moderate congestive heart failure. Eur Heart J 21:1888-95
21. Lacorte J, Cabreriza S, Rabkin D, et al. (2003). Correlation of the tei index with invasive measurements of ventricular function in a porcine model. J Am Soc Echocardiogr 16:442-7
22. Nearchou N, Tsakiris A, Lolaka M, Zarcos I, Skoufas D, Skoufas P. (2003). Influence of perindopril on left ventricular global performance during the early phase of inferior acute myocardial infarction: assessment by Tei index. Echocardiography 20:319-27
23. Poulsen S, Jensen S, Tei C, Seward J, Egstrup K. (2000). Value of the Doppler Index of Myocardial Performance in the Early Phase of Acute Myocardial Infarction. J Am Soc Echocardiogr 13:723-30
24. Jugdutt B. (1993). Prevention of ventricular remodelling post myocardial infarction: Timing and duration of therapy. Can J Cardiol 9:103-14
25. Gaudron P, Eilles C, Kugler I, Ertl G. (1993). Progressive left ventricular dysfunction and remodelling after myocardial infarction. Potential mechanisms and early predictors. Circulation 87:755-63
26. Heikkila J, Luomanmaki K, Pyorala K. (1971). Serial observations on left ventricular dysfunction in acute myocardial infarction. II Systolic time intervals in power failure. Circulation 44:343-54
27. Hodges M, Halpern B, Friesinger G, Dagenais G. (1972). Left ventricular preejection period and ejection time in patients with acute myocardial infarction. Circulation 45:933-42
28. Moller J, Dahlstrom U, Gotzsche O et al. (2004). Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: Results of the Optimal trial in myocardial infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudy. Am Heart J 147:494-501
29. Moller J, Poulsen S, Egstrup K. (1999). Effect of preload alternations on a new Dopppler echocardiographic index of combined systolic and diastolic performance. J Am Soc Echocardiogr 12:1065-72